|Year : 2020 | Volume
| Issue : 2 | Page : 312-320
Cardiac preconditioning effect of ketamine–dexmedetomidine versus fentanyl–propofol during arrested heart revascularization
Mohammed Adel Hegazy1, Refaat Abdelfattah Hegazi2, Shimaa Rabea Hendawy3, Mohamed Salah Hussein4, Amr Abdellateef5, Geha Awad5, Ola Taha Abdeldayem1
1 Department of Anesthesia and Intensive Care, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2 Department of Community Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
3 Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
4 Department of Cardiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
5 Department of Cardiothoracic Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt
|Date of Submission||11-Jun-2020|
|Date of Decision||20-Jun-2020|
|Date of Acceptance||25-Jun-2020|
|Date of Web Publication||12-Oct-2020|
Dr. Mohammed Adel Hegazy
Department of Anesthesia and Intensive Care, Mansoura University Hospitals, F1, 60, El Gomhoria Street, Qism 2, Mansoura 35516, Dakahleya Governorate
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Myocardial damage due to ischemia and reperfusion is still unavoidable during coronary surgery. Anesthetic agents have myocardial preconditioning effect. Ketamine has sympathomimetic effect, while dexmedetomidine has a sympatholytic effect in addition to anesthetic, analgesic, and anti-inflammatory properties of both the drugs. This study was carried out to compare ketamine–dexmedetomidine (KD) combination with fentanyl–propofol (FP) combination on the release of cardiac troponin T (cTnT) and outcome after coronary artery bypass graft. Patients and Methods: Ninety adult patients who underwent coronary artery bypass grafting (CABG) were assigned to receive either KD base anesthesia (KD group) or FP anesthesia (FP group). Trends of high-sensitive cTnT, CK-MB, and serum cortisol were followed in the first postoperative 24 h. Other outcomes were vital signs, weaning from cardiopulmonary bypass, tracheal extubation time, and echocardiographic findings. Results: There was a significant lower release of cTnT in KD group than FP group during its peak values at 6 h after aortic unclamping (92.01 ± 7.332 in KD versus 96.73 ± 12.532 ng.L−1 P = 0.032). significant lower levels of serum cortisol levels were noted KD group than in FP group at 6 and 12 h after aortic unclamping P < 0.001. As regard tracheal extubation time, patients assigned to KD group extubated earlier than whom in FP group 202.22 ± 28.674 versus 304.67 ± 40.598 min respectively P < 0.001. Conclusion: The use of KD during on-pump CABG confers better myocardial protective and anti-inflammatory effect than fentanyl propofol.
Keywords: Coronary artery bypass grafting, dexmedetomidine, ketamine, myocardial ischemia-reperfusion injury, troponin
|How to cite this article:|
Hegazy MA, Hegazi RA, Hendawy SR, Hussein MS, Abdellateef A, Awad G, Abdeldayem OT. Cardiac preconditioning effect of ketamine–dexmedetomidine versus fentanyl–propofol during arrested heart revascularization. Anesth Essays Res 2020;14:312-20
|How to cite this URL:|
Hegazy MA, Hegazi RA, Hendawy SR, Hussein MS, Abdellateef A, Awad G, Abdeldayem OT. Cardiac preconditioning effect of ketamine–dexmedetomidine versus fentanyl–propofol during arrested heart revascularization. Anesth Essays Res [serial online] 2020 [cited 2021 Jan 26];14:312-20. Available from: https://www.aeronline.org/text.asp?2020/14/2/312/297824
| Introduction|| |
Although there are lots of progress in the surgical field of coronary artery disease (CAD) due to the newer techniques and anesthetic protocols held in coronary artery bypass grafting (CABG), perioperative myocardial damage still remains as a remarkable obstacle that might affect postoperative outcome.
The protective effects of anesthetic agents on the myocardium gained popular attention either by the cardiac surgeons or by the anesthetists. Contemporary myocardial ischemia could potentially protect cardiac muscle from further damage: a process which was later called preconditioning.
One of the advantages of inhalational anesthetics is cardioprotective effects against myocardial ischemia–reperfusion (IR) injury which was proven in a number of animal experiments. The first clinical trial that described the myocardial preconditioning effect with isoflurane in CABG was evidenced with decreased postoperative levels of cardiac troponin I (cTnI) and Creatine kinase-MB (CK-MB).
Ketamine is a dissociative sedative and anesthetic drug with potent analgesic properties and marked sympathomimetic effects on the cardiovascular system. The use of ketamine has been encouraged for anesthesia in hemodynamically unstable patients because of its sympathomimetic actions, but there are concerns about its use in patients with CAD.
The use of dexmedetomidine has been increased as a component of general anesthesia, including cardiac surgical applications due to its sedative/hypnotic and analgesic effects, in addition to its cardioprotective properties.
Improvement in ventricular contractility after ischemic episodes was noticed with the use of fentanyl and other opioids. Besides participating in the triggering of the cascade of ischemic preconditioning, opioids might mediate their effects by activation of cardiac receptors, independent of the action of these drugs on the central nervous system.
There are many markers which reflect the magnitude of cardiac damage. Cardiac troponin T (cTnT) has been found to be the most sensitive (99%) and specific (78%).
A retrospective observational study by Riha et al. observed lower cardiac enzymes values with the use of ketamine–dexmedetomidine (KD) during CABG when compared with sevoflurane-sufentanil-based anesthesia.
The objective of this study is to compare the combined effect of KD with fentanyl–propofol (FP) as a cardiac preconditioning tool against ischemia and reperfusion injury during on-pump CABG.
| Patients and Methods|| |
This prospective randomized comparative study was designed to include 90 adult patients (the American Society of Anesthesiologists II and III) who were scheduled for elective coronary artery bypass surgery using cardiopulmonary bypass at Cardiothoracic Surgery Department at Mansoura University Hospital in the interval between January 2018 and March 2019. Approval of Institutional Board Review was obtained with number R/16.05.110, ×. Written informed consent was obtained from all patients.
Any patient with ongoing ischemia or unstable angina, acute myocardial infarction of <1-month duration, prior cardiac surgery, left ventricular ejection fraction <0.5, left bundle branch block, implantable pacemaker, preoperative administration of inotropic agents, serum creatinine higher than 1.5 mg.dL − 1, chronic liver disease, and valvular diseases and patients receiving sulfonylurea, theophylline, or allopurinol were excluded from the study.
All patients were subjected to preoperative clinical examination for the assessment of the cardiovascular function clinically; electrocardiogram (ECG), echocardiographic investigation, and coronary angiography and routine laboratory investigations were also conducted.
All preoperative cardiac medications except β-blockers were omitted on the day of surgery. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were discontinued at least 24 h before the surgery. Antiplatelet drugs were withheld at least a week prior to the surgery.
On arrival to the preanesthetic area, intravenous (i.v.) line was inserted, and 0.05 mg.kg − 1 midazolam was administered as a premedication and 10 mg morphine was injected intramuscularly to all patients. A radial artery catheter (20–22 G) was inserted under local anesthesia after doing modified Allen's test to monitor the arterial blood pressure and blood sampling during the entire procedure. Baseline high-sensitive cardiac troponin T (hs-cTnT) (Elecsys ® Troponin T assay, Hoffman-Roche), CK-MB by photometric method (Bayer, Leverkusen, Germany), and serum cortisol level (Elecsys ® serum cortisol assay, Hoffman-Roche) were measured.
Intraoperative monitoring included five-lead ECG, pulse oximetry, sidestream capnography, Foley's catheter, and core temperature.
Patients were randomly allocated using computer-generated program into one of two equal groups.
Ketamine–dexmedetomidine group: (n = 45)
Induction of anesthesia was given by i.v. 0.05 mg midazolam, 1 μg.kg −1 dexmedetomidine over 10 min, then 1–2 mg.kg −1 ketamine, and 0.15 mg.kg − 1 cisatracurium. Anesthesia was maintained by 0.2–1 μg.kg − 1.h −1 dexmedetomidine, 1–4 mg.k −1.h −1 ketamine, and cisatracurium 1–2 μg.kg −1.min −1 infusion to keep mean arterial blood pressure changes within 25% of the baseline. After completion of the surgery, the patient was transferred to the intensive care unit (ICU), fully monitored, and sedated with ketamine 0.25 mg.kg −1.h −1 and dexmedetomidine 0.2 μg.kg −1.h −1.
Fentanyl–propofol group: (n = 45)
The induction of anesthesia was by i.v. 0.05 mg midazolam, 5 μg.kg −1 fentanyl, 1–2 mg.kg − 1 propofol, and 0.15 mg.kg −1 cisatracurium. Anesthesia was maintained by 3–6 mg.kg −1.h −1 propofol, 1–4 μg.kg −1.h −1 fentanyl, and cisatracurium 1–2 μg.kg −1.min − 1 infusion to keep mean arterial blood pressure changes within 25% of the baseline. After completion of the surgery, the patient was transferred to the ICU, fully monitored, and sedated with fentanyl 0.5 μg.kg −1.h −1 and propofol 0.5 mg.kg −1.h −1.
Patients were mechanically ventilated with an oxygen-air mixture (1:1 ratio) aiming to maintain end-tidal CO2 around 35 mmHg.
A central venous catheter was inserted using Seldinger technique through the right internal jugular vein to monitor the filling pressure of the right side of the heart and infusion of vasoactive medications.
The surgical steps were standardized and performed by consultant level surgeon. Midline sternotomy was performed in all patients. The left internal mammary artery was harvested in all the patients and heparin 300 IU.kg − 1 was administered intravenously to achieve activated clotting time (ACT) of more than 450 s, ACT was repeated every 30 min. The cardiopulmonary bypass (CPB) circuit was primed with 1000 mL of Ringer's solution, with 250 mL of 20% mannitol. A nonpulsatile blood flow was adjusted at 2.4 L.min − 1.m 2 using a membrane oxygenator, with perfusion pressure maintained at between 45 and 70 mm Hg. Heparin was added as required. Cold crystalloid cardioplegic solution was used to arrest the heart and protect the myocardium. The patient temperature's was adjusted at 34°C, applying α-stat acid–base management.
Fluid administration strategy was maintained by Ringer's lactate to maintain CVP around 8 mmHg. Blood transfusion triggered when hemoglobin was 8 g.dL − 1 ± 1.
Hemodynamic measurements of heart rate (HR) and mean arterial pressure (MBP) were recorded (Nihon-Kohden BSM 3000 series) at baseline before anesthesia induction, immediate after intubation, at skin incision, at sternotomy, and every 15 min in the 1st h then every 30 min till the end of surgery.
Number of grafts, duration of CPB and aortic cross-clamping, number of patients required inotropic support, nitroglycerine and intra-aortic balloon pump (IABP), and defibrillation use were also recorded.
Hypotension was managed by norepinephrine perfusion and increasing i.v. fluid administration. Bradycardia (HR <40 b.p.m.) was managed by atropine sulfate 0.5 mg increment. Hypertension (MBP > 25% of basal value) was managed through a bolus dose of anesthetics (e.g., 1 μg.kg −1 dexmedetomidine in KD group and 1 μg.kg −1 fentanyl in FP group) and if persist, nitroglycerine was infused. Tachycardia (HR >100 b.p.m.) without hypertension was managed by i.v. propranolol 0.2 mg increment till effect. Blood glucose was maintained between 110 and 180 mg.dl −1 using insulin infusion as required. Weaning from CPB was completed after ensuring optimal filling pressure and hemodynamics using volume, vasoactive and inotropic medications.
The trachea was extubated after ensuring normothermia, absence of significant bleeding, normal metabolic and electrolyte milieu, and hemodynamic stability (PaO2 > 70 mmhg, PaCO2 <45 mmHg, pH 7.3–7.5, FiO2 <0.4, adrenaline <50 ng/kg/min, and adequate cough and swallowing).
cTnT (hs-cTnT), CK-MB, and serum cortisol levels at 1, 6, 12, and 24 h were measured after aortic unclamping to detect evidence of myocardial injury. Echocardiography was done on arrival to the ICU and on the 1st postoperative day. All samples were immediately centrifuged for 10 min at 3000 revolutions per minute and analyzed.
Sample size calculation
The power of this clinical trial was prospectively calculated using the G power analysis program. Sample size of the study calculation was based on cTnT concentration 6 h after aortic unclamping as the primary outcome variable; a difference of 20% between treatment groups was considered clinically significant. type 1 error was assumed to be 0.05 and power of 80%, 82 patients (41 patients in each group). We added 4 cases to each group to compensate for drop outs. Total number was 90 oatients (45 patients was included in each group).
Statistical analysis was done using the SPSS program version 22 for Windows (IBM Corporation, Armonk, NY, USA). Data were expressed as mean ± standard deviation (SD). The changes in quantitative data were done by Shapiro–Wilk's W test. Changes in values between the two groups were compared using unpaired t-test. Fisher's exact test and Chi-square test were used for qualitative data.
| Results|| |
A total number of 108 patients underwent coronary artery bypass graft using CPB were screened for eligibility and 90 patients were enrolled in this study, 45 patients in each group as shown in flowchart [Figure 1].
There was no significant difference between both groups as regard age, sex, body mass index, NYHA class, and incidence of comorbid diseases (hypertension, diabetes mellitus, and previous myocardial infarction). Preoperative medications were comparable in both the groups [Table 1].
|Table 1: Demographic data and preoperative medications of the studied groups: Data are expressed in number percentage, mean±standard deviation, and median (range)|
Click here to view
In KD group, anesthesia was induced with 0.05 (0.04–0.09) mg.kg − 1 (median [range]) of midazolam and 1.7 (0.4–2.91) mg.kg − 1 of ketamine and 1.9 (1.6–2.5) μg.kg − 1 of dexmedetomidine. In FP group, induction of anesthesia was given by 0.05 (0.031–0.086) mg.kg − 1 of midazolam, 3 (1.5–5.4) μg.kg − 1 of fentanyl, and 1.7 (1.1–2.3) mg.kg − 1 of propofol. The trachea was intubated using of 0.9 mg of rocuronium in both the groups.
For maintenance of anesthesia, total doses of 10.12 (5.79–14.96) μg.kg − 1 of fentanyl and 12.6 (4.4–24.73) mg.kg −1 of propofol were used in the FP group, while 10.9 (2.7–18.1) mg.kg −1 of ketamine, 2.13 (1.7–2.9) μg.kg −1 of dexmedetomidine were used in the KD group.
HR and MBP readings were higher in the KP group than the FP group, but this rise had no statistical significance, but MBP at intubation was 109.42 ± 8.609 and 99.76 ± 8.345 mmHg in KD and FP groups, respectively, with P < 0.001, as shown in [Figure 2] and [Figure 3].
Eleven patients in the KD group needed nitroglycerine infusion (more than 30 min.) in the face of 9 patients in the FP group (P = 0.714). The number of patients required inotropic support was comparable between both the groups, 5 patients in KD group had vasoactive inotropic score (VIS) >15 in face of 13 patients in FP group P < 0.001 as shown in [Table 2].
|Table 2: Surgical and cardiopulmonary bypass weaning data in the studied groups|
Click here to view
In KD group, two patients developed bradycardia that required intervention in the face of no one in the FP group (P = 0.438).
As regards tracheal extubation time, patients assigned to KD group extubated earlier than whom in FP group 202.22 ± 28.674 versus 304.67 ± 40.598 min, respectively, P < 0.001. Surgical and CPB weaning data are shown in [Table 2].
Hs-cTnT showed an insignificant difference between both the groups either preoperatively or 1, 12, and 24 h after aortic unclamping but significantly lower in the KD group at 6 h postunclamping 92.01 ± 7.332 in KD versus 96.73 ± 12.532 ng.L − 1 P = 0.032 [Table 3] and [Figure 4]. CK-MB levels were comparable in both the groups [Table 4].
|Table 3: High-sensitive cardiac troponin T-enzyme in the studied groups: Data are expressed in mean±standard deviation|
Click here to view
|Figure 4: High-sensitive cardiac troponin T-enzyme in the studied groups|
Click here to view
|Table 4: Creatinine phosphokinase-myocardial bound (creatine kinase-myocardial band) in the studied groups: data are expressed in mean±standard deviation|
Click here to view
Patients in the KD group expressed significantly lower levels of serum cortisol levels than patients in the FP group at 6 and 12 h after aortic unclamping P < 0.001 at both the times, as shown in [Figure 5].
As regards echocardiographic examination, the number of patients showed regional wall motion abnormality (RWMA) expressed in (Nu and %) and left ventricular ejection fraction (LVEF) expressed in mean ± SD showed no statistically significant difference between both the groups [Table 5].
|Table 5: Echocardiographic findings in the studied groups: data are expressed in numbers percentage and mean±standard deviation|
Click here to view
| Discussion|| |
The current study showed that no statistically significant difference between both the groups as regard cTnT except at 6 h postaortic unclamping (92.01 ± 7.332, 96.73 ± 12.532 ng/L, respectively, P = 0.032 with 95% confidence interval − 9, −0.42, respectively). Patients assigned to KD group exhibited a significant decrease in serum cortisol level, so we can claim that a combination of ketamine and dexmedetomidine offers myocardial protection during peaked hs-cTnT and marked anti-inflammatory effect when compared with fentanyl propofol combination during on-pump CABG.
A study by Riha et al. observed lower cardiac enzymes values with the use of KD during CABG when compared with sevoflurane-sufentanil-based anesthesia. Although our results agreed with them to some extent, their study has major limitations and differences with us. The nature of their study was a retrospective observational. It included a limited number of patients, also diabetic patients on sulfonylurea were not excluded, which is known to inhibit cardiac preconditioning. We excluded any patient on any medications which are known to inhibit any probable myocardial protection. They used opioids in both the groups and opioid receptors are known to play a role in cardiac preconditioning which pose a strong drawback. They used inhalational anesthetic (sevoflurane) in one group, while we used total i.v. anesthesia in both the groups and we offered a precise number about the doses of the used drugs. They followed biomarkers of myocardial injury on arrival to the ICU and then on the 1st postoperative day; these times are not constant to specific event as aortic unclamping. They could not follow-up the changes in cardiac enzymes during first postoperative 24 h which represent the peak of cardiac enzymes elevation. Riha et al. could not prove the anti-inflammatory effect of KD combination. They did not investigate the effect of the study drugs on hemodynamics during stress times as intubation, skin incision, and sternotomy. They did not investigate the impact of the study drugs on weaning from cardiopulmonary bypass in terms of vasoactive inotropic score. In our study, infusion of study drugs was continued in the ICU till extubation and time to tracheal extubation was recorded and analyzed. We used hs-cTnT which is very sensitive to small myocardial injury.
The development of high-sensitivity troponin assays enabled identification of small-scale myocardial injuries, allowing the detection of even small myocardial injuries. Following myocardial injury, there are two peaks of cTnT release including early peak at 3–5 h and late one on the 5th day after cell necrosis.
In a pragmatic, multicenter, randomized, single-blind trial involving patients undergoing elective, isolated CABG, when intraoperative anesthesia was compared with a volatile anesthetic. Moreover, a composite of perioperative nonfatal myocardial infarction at 30 days or death at 30 days and other major secondary outcomes did not differ significantly between the two groups.
However, racemic ketamine reported to inhibit ischemic preconditioning in vivo by inhibiting sarcolemmal adenosine triphosphate-sensitive potassium ATP channels; other experiments showed that a racemic mixture of ketamine and its S-(+)-enantiomer could trigger myocardial preconditioning in vitro. This effect is mediated by the activation of ATP potassium channels and stimulation of α- and ß-adrenergic receptors.
When ketamine was used as the sole analgesic during cardiac surgery, it reduced the inflammatory cytokine response associated with extracorporeal circulation. Furthermore, ketamine might promote the production of anti-inflammatory cytokines after major surgery, as was suggested by the significantly higher plasma concentrations of interleukin-10 at the end of surgery compared with sufentanil-based analgesia.
Induction and maintenance of anesthesia with ketamine might carry some risks. Due to its sympathomimetic effects, it may lead to hypertension and tachycardia which may increase myocardial oxygen demand, so dexmedetomidine is added as an adjunct in KD group.
Cardiovascular mortality and morbidity can be decreased with the sympatholytic effects of α2-receptor agonists in patients with CAD. Perioperative dexmedetomidine use might also confer an early postoperative benefit for cardiac surgical patients with the well-proven benefits of sympatholytic, anti-inflammatory, and anti-delirium effects in the setting of cardiac surgery.
Studies have shown that dexmedetomidine provides protective effects on the myocardium. α2-Adrenergic agonists have protective effects against myocardial ischemia by increasing the cAMP level which further induces coronary vasodilatation effect. Dexmedetomidine preconditioning has been shown to attenuate myocardial ischemia/reperfusion injury through activating prosurvival kinases.
The meta-analysis included 18 studies included 1730 patients that compared dexmedetomidine to other treatments in the setting of cardiac surgery, most of the findings agreed with its myocardial protective results in the adult population. Gong et al. included a total of 8 randomized controlled trials discussed the use of dexmedetomidine in cardiac surgery, their results revealed that a lower risk of delirium, a shorter length of intubation, but a higher incidence of bradycardia were found in dexmedetomidine group when compared with propofol. There were no statistically significant differences in the risks of hypotension or atrial fibrillation or the time of ICU stay between dexmedetomidine and propofol regimens. Unlike their ICU stay result, it was observed a significantly shorter stay in ICU with dexmedetomidine.
Studies on human subjects have not reported cardioprotective effects for propofol. Compared with isoflurane, the use of only high-dose propofol during CPB led to reduced levels of cardiac enzymes in patients undergoing CABG. Conversely, compared with isoflurane, normal doses of propofol did not produce altered cTnI levels.
Most studies have found δ- and κ-receptors, but not μ-receptors are expressed in cardiomyocytes. More specifically κ1 was reported in the crude membrane preparation of a rat heart homogenate, and both κ- and δ-, but not μ-receptors, have been identified in rat atrial and ventricular tissue. Fentanyl is considered to be selective for μ-receptors; it can also interact with δ- and κ-receptors. Fentanyl protects the heart against myocardial IR injury via δ-receptor crosstalk with adenosine A1-receptors and mitochondrial K ATP-linked mechanisms.
Although ketamine is known to increase HR and blood pressure, we observed no statistically significant difference in HR readings between both the groups. The mean blood pressure was significantly higher in the KD group than the FP group (109.42 ± 8.609 and 99.76 ± 8.345 mmHg, respectively, P < 0.001). The concomitant use of dexmedetomidine blunted the expected tachycardic effect of ketamine in the KD group during the induction of anesthesia.
An i.v. bolus administration of dexmedetomidine, which results in a high (peak) plasma concentration, results in an increase in blood pressure combined with a marked decrease in HR. During this phase, a marked rise in systemic vascular resistance is mediated by α2-receptor activation in the vascular smooth muscles. This is accompanied by a rapid decrease in HR, presumably caused by the baroceptor reflex. Later on, when dexmedetomidine plasma concentrations decrease, the vasoconstriction attenuates, as dexmedetomidine also activates α2-receptors in the vascular endothelial cells causing vasodilatation. Together with presynaptic α2-adrenoreceptors inhibiting the sympathetic release of catecholamines and the increased vagal activity, this results in a hypotensive phase.
Patel et al. found that the combination of clonidine and ketamine in anesthesia induction during CABG led to a smaller decrease in vital signs after induction agent being delivered, along with effective suppression of the pressure response to laryngoscopy and endotracheal intubation; the lowest rise in HR and blood pressure was in the group clonidine and ketamine when compared with baseline readings.
Our results agreed with Patel results except MBP at intubation which was higher in the KD group. This may be owing to their use of fentanyl together with clonidine and ketamine during induction.
During anesthesia maintenance, HR and mean blood pressure were running with no statistically significant difference between both the groups. Clonidine with ketamine produced stable hemodynamics. This indicates effective clonidine-mediated central sympatholytic action.
Our results revealed no statistically ;tatistical significance in the number of patients that required inotropic support, however, the number of patients that needed a high dose of vasoactive inotropic medications (VIS score > 15) was significantly lower in KD group (5 patients) than FP group (13 patients) P = 0.035.
The issue of cardiac output and ketamine showed some controversies. Some authors thought that ketamine has a direct myocardial depression, whereas others reported that ketamine augments cardiac output through an indirect way by catecholamines potentiation. Other studies demonstrated direct positive ionotropic effects of ketamine on human myocytes.
Tracheal extubation time was significantly shorter in the KD group than the FP group (202.22 ± 28.674 vs. 304.67 ± 598 min respectively P < 0.00). Elimination of infused medications depends on their context sensitive half-life which is the time required for drug concentration to decrease to half of its value after a given duration of drug infusion. Each drug has its special characteristics. Fentanyl has a short 50% drug declining times if infused for 15 min. Thereafter, the time for fentanyl increases rapidly toward clinically unreasonable half-times which could reach more than 200 min if infused for 4 h. Most hypnotic agents exhibit short context-sensitive half-times. The elimination half-life of dexmedetomidine is 2–3 h when infused in ICU.
Dexmedetomidine decreases anesthetic requirements either volatile or i.v. agents by exerting an opioid-sparing effect. A great advantage for dexmedetomidine is a minimal respiratory depression in contrast to fentanyl which has a marked effect. These factors predispose to early quiet tracheal extubation.
There are some limitations of this study; we did not follow-up on the cardiac enzyme till it reach back to baseline. We did not monitor the effect of combined drugs on more invasive and complex hemodynamics using a pulmonary artery catheter. This was because of relatively low-risk profile of the patients. This could be investigated in a further study using a Swan Ganz catheter or using transesophageal echocardiography. Another limitation is that we did not examine the impact of dexmedetomidine on the negative psychotropic experience of ketamine; however, this is out of scope of our study.
| Conclusion|| |
This study suggests that the use of KD during on-pump CABG confers better myocardial protective and anti-inflammatory effect than fentanyl propofol.
Financial support and sponsorship
Mansoura University, Mansoura, Egypt.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Imantalab V, Nejad AS, Mansouri AM, Meibodi AS, Haghighi M, Dadkhah, H, et al
. A comparative study of cardioprotective effect of three anesthetic agents by measuring serum level of troponin-T after coronary artery bypass grafting. Int Cardiovascular Res J 2012;6:70.
Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
De Hert SG, Preckel B, Schlack WS. Update on inhalational anaesthetics. Curr Opin Anaesthesiol 2009;22:491-5.
Riha H, Kotulak T, Brezina A, Hess L, Kramár P, Szarszoi O, et al
. Comparison of the effects of ketamine-dexmedetomidine and sevoflurane-sufentanil anesthesia on cardiac biomarkers after cardiac surgery: An observational study. Phys Res 2012;61:63.
Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol 2016;32:160.
] [Full text]
Neuhäuser C, Preiss V, Feurer MK, Müller M, Scholz S, Kwapisz M, et al
. Comparison of S-(+)-ketamine-with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: Effect on troponin T levels. Br J Anaesth 2008;100:765-71.
Easley RB, Tobias JD. Pro: Dexmedetomidine should be used for infants and children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:147-51.
LaDisa JF Jr., Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Cardioprotection by glucose-insulin-potassium: Dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol 2004;287:H601-7.
Suryaprakash S, Chakravarthy M, Muniraju G, Pandey S, Mitra S, Shivalingappa B, et al
. Myocardial protection during off pump coronary artery bypass surgery: A comparison of inhalational anesthesia with sevoflurane or desflurane and total intravenous anesthesia. Ann Cardiac Anaesth 2013;16:4.
Riha H, Kotulak T, Brezina A, Hess L, Kramár P, Szarszoi O, et al
. Comparison of the effects of ketamine-dexmedetomidine and sevoflurane-sufentanil anesthesia on cardiac biomarkers after cardiac surgery: An observational study. Phys Res 2012;61:63.
Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah AS, et al
. Application of high-sensitivity troponin in suspected myocardial infarction. New England J Med 2019;380:2529-40.
Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ 2005;173:1191-202.
Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, et al
. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. New England J Med 2019;380:1214-25.
Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tanaka K, Tomiyama Y, et al
. Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiol Hagerstown 2005;102:93-101.
Hanouz JL, Zhu L, Persehaye E, Massetti M, Babatasi G, Khayat A, et al
. Ketamine preconditions isolated human right atrial myocardiumroles of adenosine triphosphate-sensitive potassium channels and adrenoceptors. Anesthesiology 2005;102:1190-6.
Welters ID, Feurer MK, Preiss V, Müller M, Scholz S, Kwapisz M, et al
. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth 2011;106:172-9.
Kabukçu HK, Sahin N, Temel Y, Titiz TA. Hemodynamics in coronary artery bypass surgery: Effects of intraoperative dexmedetomidine administration. Anaesthesist 2011;60:427-31.
Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, et al
. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation 2013;127:1576-84.
Ibacache M, Sanchez G, Pedrozo Z, Galvez F, Humeres C, Echevarria G, et al
. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochimica et Biophysica Acta (BBA) Molec Basis Dis 2012;1822:537-45.
Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: A systematic review and meta-analysis. PLoS One 2018;13:e0202620.
Gong Z, Ma L, Zhong YL, Li J, Lv J, Xie YB. Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic review. Exp Therap Med 2017;13:2355-61.
Kendall JB, Russell GN, Scawn ND, Akrofi M, Cowan CM, Fox MA. A prospective, randomised, single-blind pilot study to determine the effect of anaesthetic technique on troponin T release after off-pump coronary artery surgery. Anaesthesia 2004;59:545-9.
Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: A comparison with isoflurane. Anesth Analg 2006;103:527-32.
Flier S, Post J, Concepcion AN, Kappen TH, Kalkman CJ, Buhre WF. Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 2010;105:122-30.
Tanaka K, Kersten JR, Riess ML. Opioid-induced cardioprotection. Curr Pharm Design 2014;20:5696-705.
Xu Q, Li QG, Fan GR, Liu QH, Mi FL, Liu B. Protective effects of fentanyl preconditioning on cardiomyocyte apoptosis induced by ischemia-reperfusion in rats. Br J Med Biol Res 2017;50.
Ebert TJ. Is gaining control of the autonomic nervous system important to our specialty? Anesthesiology 1999;90:651-3.
Weerink MA, Struys MM, Hannivoort LN, Barends CR, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharm 2017;56:893-913.-
Patel J, Thosani R, Kothari J, Garg P, Pandya H. Clonidine and ketamine for stable hemodynamics in off-pump coronary artery bypass. Asian Cardiovasc Thorac Ann 2016;24:638-46.
Klockgether-Radke AP, Huneck S, Meyberg S, Neumann P, Hellige G. Ketamine enantiomers differentially relax isolated coronary artery rings. Europ J Anaesthesiol 2005;22:215-21.
Hanouz JL, Persehaye E, Zhu L, Lammens S, Lepage O, Massetti M, Gérard JL. The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: The effect of adrenoceptor blockade. Anesthesia Analgesia 2004;99:1689-95.
Keifer J. Glass, peter context-sensitive half-time and anesthesia: How does theory match reality? Curr Opinion Anaesthesiol 1999;12:443-8.
Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998;53 Suppl 1:4-12.
Song J, Ji Q, Sun Q, Gao T, Liu K, Li L. The opioid-sparing effect of intraoperative dexmedetomidine infusion after craniotomy. J Neurosurg Anesthesiol 2016;28:14-20.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]